DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

United Therapeutics Corp (NASDAQ: UTHR)



company name or ticker
Company Photos
(Click to zoom)

Chelsea's Northera Gets Another Chance

A January advisory panel meeting and potential FDA approval in February could move the needle for this small biotech.

Pluristem Touches 52-Week High - Analyst Blog

Pluristem Touches 52-Week High - Analyst Blog

Analyst Favorites With Strong Buyback Activity: United Therapeutics Ranks As A Top Pick

Insider Trading Alert - SPLK, UTHR, IBKR, CMLS And SPG Traded By Insiders

This Week in Biotech

An FDA approval, a mixed batch of clinical data, a welcome pipeline update, and an ongoing patent battle are this week's must-watch biotech stories.

3 Humongous Health-Care Stocks This Week

Which health-care stocks stood out as the most humongous winners this week? Provectus, Inovio, and United Therapeutics take the honors.

United Therapeutics Surges After FDA Approval - Analyst Blog

United Therapeutics Surges After FDA Approval - Analyst Blog

High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares

High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares

High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares

High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares

Why You Need To Watch Johnson & Johnson, Synergy, Sagent, and Supernus This Morning

Johnson & Johnson, Synergy, Sagent, and Supernus could make health care headlines this morning. Here’s why.
See More Articles...